- Exchange: SIX Swiss Ex
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Santhera Pharmaceutical Holding AG
Add to PortfolioSANN:SW
4.01 CHF 0.28 6.53%As of 11:31:34 ET on 05/25/2012.
Snapshot for Santhera Pharmaceutical Holding AG (SANN)
| Open: | 4.26 | Day's Range: | 3.93 - 4.35 | Volume: | 5,336 | Bid: | 4.01 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 4.29 | 52wk Range: | 3.74 - 9.15 | 1-Yr Rtn: | -52.82% | Ask: | 4.05 |
Key Statistics for SANN
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (CHF) (ttm) | -7.6000 |
| Est. EPS (CHF) (12/2012) | -7.7400 |
| Est. PEG Ratio | - |
| Market Cap (M CHF) | 14.73 |
| Shares Outstanding (M) | 3.67 |
| Enterprise Value (M CHF) (ttm) | - |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 0.3420 |
| Price/Sale (ttm) | 4.5015 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/31/2012 |
More SANN Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for SANN
- Operating
- Investing
- Financing (M/CHF)
Company Profile & Key Executives for SANN
Santhera Pharmaceuticals is a drug discovery and development company. The Company focuses on the discovery, preclinical and clinical development, and commercialization of pharmaceuticals for neuromuscular and metabolic diseases.
| Michael E LyttonChairman | Hans Peter HaslerVice Chairman |
| Klaus SchollmeierChief Executive Officer | Helmut KessmannChief Business Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page